
Health
07 Feb 2020
Seeing blue after the little blue pill: visual disturbances in sildenafil users
Some men taking the highest recommended dose of sildenafil reported blurred vision, light sensitivity and color issues: Frontiers in Neurology

Health
07 Feb 2020
Some men taking the highest recommended dose of sildenafil reported blurred vision, light sensitivity and color issues: Frontiers in Neurology

Health
06 Feb 2020
Highly toxic titanium oxide found in coal smog can cause lung damage in mice after a single exposure: Frontiers in Immunology

Health
15 Jan 2020
Most probiotic information online originates from unreliable sources: Frontiers in Medicine

Health
12 Dec 2019
Two joint papers demonstrate that administering oxygen can help premature babies breathe independently sooner: Frontiers in Pediatrics

Health
04 Dec 2019
Using small amounts of Manuka honey between layers of surgical mesh acts as a natural antibiotic.

Health
03 Dec 2019
A certain herpes variant may have a role in the development of multiple sclerosis: Frontiers in Immunology

Health
25 Nov 2019
Chronic and hidden hunger affect nearly half of rural households in sub-Saharan Africa: Frontiers in Sustainable Food Systems

Health
24 Oct 2019
Exposure of the skin to UVB light alters the mix of bacteria found in the gut, possibly via vitamin D; Frontiers in Microbiology

Health
18 Oct 2019
Lyme disease is one of medicine’s great mimics, and notoriously difficult to diagnose. A new study has uncovered six potential biomarkers for accurate and early identification; Frontiers in Cellular and Infection Microbiology

Health
14 Oct 2019
A high salt diet inhibited tumor growth in two independent mouse models; Frontiers in Immunology

Health
23 Sep 2019
After decades of mouse studies, bacterial immunotherapy looks set for a return to oncology clinics; Frontiers in Oncology

Health
12 Sep 2019
Linked with obesity, esophageal cancer is one of the fastest growing cancers in the Western world. Image: Shutterstock. Finding new ways to reverse the inhibition of ‘MAIT’ immune cells could transform the prognosis of esophageal cancer — by Trinity College Dublin Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target. Their research is published in Frontiers in Immunology. Esophageal cancer is a very aggressive type of cancer with poor prognosis, and the 5-year survival rate is typically less than 15%. Linked with obesity, esophageal cancer is one of the fastest growing cancers in the Western world and incidence is due to double in Ireland within the next few decades. Current treatment strategies work well but only for a minority (approx. 25%) of patients so new treatment options are urgently needed. New treatment strategies targeting the immune system have had revolutionary effects in other cancer types, but the latest clinical trials show that, disappointingly, immunotherapy offers no real benefit for the majority of patients with oesophageal cancer. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma► Read original […]

Health
11 Sep 2019
Johns Hopkins team develops donor screening for vaginal microbiota transplantation; Frontiers in Cellular and Infection Microbiology

Health
09 Aug 2019
Focusing on movement instead of muscle can enhance weightlifting performance, suggests research; Frontiers in Sports and Active Living

Health
07 Aug 2019
Experts call for better regulation of a common additive in foods and medicine, as research reveals it can impact the gut microbiota and contribute to inflammation in the colon; Frontiers in Nutrition
Get the latest research updates, subscribe to our newsletter